Barclays’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.21M | Buy |
804,112
+401,512
| +100% | +$3.6M | ﹤0.01% | 1356 |
|
|
2025
Q1 | $3.02M | Sell |
402,600
-61,646
| -13% | -$462K | ﹤0.01% | 1757 |
|
|
2024
Q4 | $3.49M | Sell |
464,246
-12,426
| -3% | -$93.5K | ﹤0.01% | 1843 |
|
|
2024
Q3 | $3.62M | Buy |
476,672
+250,086
| +110% | +$1.9M | ﹤0.01% | 1749 |
|
|
2024
Q2 | $1.4M | Sell |
226,586
-49,672
| -18% | -$307K | ﹤0.01% | 1923 |
|
|
2024
Q1 | $1.4M | Sell |
276,258
-428,271
| -61% | -$2.18M | ﹤0.01% | 2179 |
|
|
2023
Q4 | $4.22M | Buy |
704,529
+157,201
| +29% | +$942K | ﹤0.01% | 1621 |
|
|
2023
Q3 | $3.88M | Sell |
547,328
-2,411
| -0.4% | -$17.1K | ﹤0.01% | 1291 |
|
|
2023
Q2 | $3.87M | Sell |
549,739
-153,434
| -22% | -$1.08M | ﹤0.01% | 1361 |
|
|
2023
Q1 | $5.86M | Buy |
703,173
+218,681
| +45% | +$1.82M | ﹤0.01% | 1000 |
|
|
2022
Q4 | $5.56M | Buy |
484,492
+72,976
| +18% | +$838K | ﹤0.01% | 1056 |
|
|
2022
Q3 | $5.18M | Buy |
411,516
+324,633
| +374% | +$4.09M | 0.01% | 1077 |
|
|
2022
Q2 | $918K | Sell |
86,883
-35,444
| -29% | -$374K | ﹤0.01% | 2158 |
|
|
2022
Q1 | $1.99M | Sell |
122,327
-96,205
| -44% | -$1.56M | ﹤0.01% | 1780 |
|
|
2021
Q4 | $3.03M | Buy |
218,532
+139,616
| +177% | +$1.93M | ﹤0.01% | 1550 |
|
|
2021
Q3 | $1.13M | Sell |
78,916
-3,253
| -4% | -$46.7K | ﹤0.01% | 2186 |
|
|
2021
Q2 | $1.3M | Sell |
82,169
-153,124
| -65% | -$2.42M | ﹤0.01% | 1966 |
|
|
2021
Q1 | $2.39M | Buy |
235,293
+137,263
| +140% | +$1.4M | ﹤0.01% | 1717 |
|
|
2020
Q4 | $730K | Sell |
98,030
-189,675
| -66% | -$1.41M | ﹤0.01% | 2138 |
|
|
2020
Q3 | $987K | Sell |
287,705
-86,006
| -23% | -$295K | ﹤0.01% | 1933 |
|
|
2020
Q2 | $1.78M | Sell |
373,711
-775,135
| -67% | -$3.69M | ﹤0.01% | 1547 |
|
|
2020
Q1 | $2.3M | Buy |
1,148,846
+949,442
| +476% | +$1.9M | ﹤0.01% | 1273 |
|
|
2019
Q4 | $688K | Sell |
199,404
-33,802
| -14% | -$117K | ﹤0.01% | 2512 |
|
|
2019
Q3 | $669K | Sell |
233,206
-127,631
| -35% | -$366K | ﹤0.01% | 2468 |
|
|
2019
Q2 | $1.37M | Buy |
360,837
+255,012
| +241% | +$967K | ﹤0.01% | 2114 |
|
|
2019
Q1 | $861K | Buy |
105,825
+64,891
| +159% | +$528K | ﹤0.01% | 2257 |
|
|
2018
Q4 | $330K | Sell |
40,934
-4,214
| -9% | -$34K | ﹤0.01% | 2487 |
|
|
2018
Q3 | $345K | Buy |
45,148
+34,050
| +307% | +$260K | ﹤0.01% | 2815 |
|
|
2018
Q2 | $64K | Sell |
11,098
-18,376
| -62% | -$106K | ﹤0.01% | 3219 |
|
|
2018
Q1 | $140K | Buy |
29,474
+5,801
| +25% | +$27.6K | ﹤0.01% | 3013 |
|
|
2017
Q4 | $116K | Buy |
23,673
+8,778
| +59% | +$43K | ﹤0.01% | 2935 |
|
|
2017
Q3 | $78K | Sell |
14,895
-147,821
| -91% | -$774K | ﹤0.01% | 2795 |
|
|
2017
Q2 | $904K | Buy |
162,716
+138,029
| +559% | +$767K | ﹤0.01% | 1616 |
|
|
2017
Q1 | $208K | Sell |
24,687
-37,777
| -60% | -$318K | ﹤0.01% | 2480 |
|
|
2016
Q4 | $396K | Buy |
62,464
+61,050
| +4,318% | +$387K | ﹤0.01% | 1955 |
|
|
2016
Q3 | $7K | Sell |
1,414
-17,159
| -92% | -$84.9K | ﹤0.01% | 3341 |
|
|
2016
Q2 | $52K | Sell |
18,573
-2,095
| -10% | -$5.87K | ﹤0.01% | 2554 |
|
|
2016
Q1 | $41K | Buy |
20,668
+3,231
| +19% | +$6.41K | ﹤0.01% | 2600 |
|
|
2015
Q4 | $175K | Sell |
17,437
-63,280
| -78% | -$635K | ﹤0.01% | 2095 |
|
|
2015
Q3 | $887K | Buy |
80,717
+31,633
| +64% | +$348K | ﹤0.01% | 1473 |
|
|
2015
Q2 | $686K | Buy |
49,084
+45,902
| +1,443% | +$642K | ﹤0.01% | 1644 |
|
|
2015
Q1 | $29K | Sell |
3,182
-3,109
| -49% | -$28.3K | ﹤0.01% | 2968 |
|
|
2014
Q4 | $75K | Sell |
6,291
-4,817
| -43% | -$57.4K | ﹤0.01% | 2811 |
|
|
2014
Q3 | $100K | Sell |
11,108
-4,147
| -27% | -$37.3K | ﹤0.01% | 2637 |
|
|
2014
Q2 | $182K | Buy |
15,255
+4,915
| +48% | +$58.6K | ﹤0.01% | 2439 |
|
|
2014
Q1 | $103K | Sell |
10,340
-13,668
| -57% | -$136K | ﹤0.01% | 2771 |
|
|
2013
Q4 | $168K | Sell |
24,008
-2,082
| -8% | -$14.6K | ﹤0.01% | 2742 |
|
|
2013
Q3 | $183K | Sell |
26,090
-143,196
| -85% | -$1M | ﹤0.01% | 2661 |
|
|
2013
Q2 | $262K | Buy |
+169,286
| New | +$262K | ﹤0.01% | 2555 |
|